玻璃体切除术后迟发性高眼压:6048眼多中心研究
结果显示,6048眼中294眼(4.9%)发生LOH,显著高于对侧眼87眼(1.4%);术中曲安奈德使用、较长眼轴、术前较高眼压及术后人工晶状体/无晶状体状态是LOH的显著危险因素。
要点
- 玻璃体切除术后迟发性高眼压发生率为4.9%,显著高于对侧眼1.4%。
- 术中曲安奈德使用是LOH最强预测因素(OR 7.62)。
- 术后人工晶状体/无晶状体状态、较长眼轴及术前较高眼压亦为危险因素。
核心结论
- 迟发性高眼压发生于4.9%的玻璃体切除眼,主要危险因素为术中曲安奈德使用和术后人工晶状体/无晶状体状态。
主要发现
- 6048眼中294眼(4.9%)发生LOH,对侧眼87眼(1.4%)发生LOH,差异有统计学意义(卡方检验,P < 0.001)。
- 多因素logistic回归显示LOH显著危险因素包括术中曲安奈德使用(OR 7.62,P < 0.001)、较长眼轴(OR 1.55,P = 3.023)、术前较高眼压(OR 1.81,P = 0.003)及术后人工晶状体/无晶状体状态(OR 2.04,P < 0.001)。
- 决策树分析显示LOH最强预测因素为术中曲安奈德使用(P < 0.001);在使用了曲安奈德的眼睛中,术前眼压超过15 mmHg为次要预测因素(P < 0.001);在未使用曲安奈德的眼睛中,术后人工晶状体/无晶状体状态为次要预测因素(P = 0.007)。
关键数值与推荐
- LOH定义为玻璃体切除术后超过2个月、至少连续2次随访检测到眼压 > 21 mmHg。
临床怎么用
- 玻璃体切除术后应关注迟发性高眼压,尤其对术中使用曲安奈德、术后人工晶状体/无晶状体状态、较长眼轴或术前较高眼压的患者进行术后眼压监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the incidence and risk factors for late-onset ocular hypertension (LOH) after vitrectomy. METHODS: From the electronic medical records of consecutive patients who underwent primary vitrectomy, from January 2010 to December 2015, at 5 tertiary vitreoretinal centers in Italy, patient demographics, systemic, ophthalmic, operative, and postoperative data were drawn. Main outcome measure was the presence of LOH, defined as intraocular pressure >21 mmHg detected more than 2 months after vitrectomy on at least 2 consecutive visits. RESULTS: Among 6,048 patients, LOH was found in 294 (4.9%) vitrectomized eyes and in 87 (1.4%) fellow eyes, (chi square; P < 0.001). Multivariable logistic regression showed that significant risk factors for developing LOH included intraoperative triamcinolone use (odds ratio [OR], 7.62; P < 0.001), longer axial length (OR, 1.55; P = 3.023), preoperative higher intraocular pressure (OR, 1.81; P = 0.003), and postvitrectomy pseudophakic/aphakic status (OR, 2.04; P < 0.001). Decision-tree analysis showed that the stronger predictor of LOH was intraoperative triamcinolone use (P < 0.001). Secondary predictors were a preoperative intraocular pressure more than 15 mmHg (P < 0.001) in eyes that use triamcinolone, and postvitrectomy pseudophakic/aphakic status (P = 0.007) in eyes that did not use triamcinolone. CONCLUSION: Late-onset ocular hypertension occurred in 4.9% of vitrectomized eyes. The main risk factors were intraoperative use of triamcinolone and postvitrectomy pseudophakic/aphakic status.
引用
- Reibaldi M, Avitabile T, Russo A, et al. LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes. Retina. 2019. PMID: 30161094. doi:10.1097/IAE.0000000000002309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。